George V Migausky Immunovant, Inc. (IMVT) insider trading activity

George V Migausky is Director of Immunovant, Inc.. Currently has a direct ownership of 137,251 shares of IMVT, which is worth approximately $3.78 Million. The most recent transaction as insider was on Apr 01, 2025, when has been sold 16,188 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 137K

13.37% 3M change

13.37% 12M change

Total Value Held $3.78 Million

GEORGE V MIGAUSKY Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 01 2025	BUY Grant, award, or other acquisition	-	16,188 Added 10.55%	137,251 Common Stock
Apr 02 2024	BUY Grant, award, or other acquisition	-	11,255 Added 8.51%	121,063 Common Stock
Dec 01 2023	SELL Open market or private sale	$504,063 $39.69 p/Share	12,700 Reduced 10.37%	109,808 Common Stock
Apr 12 2023	BUY Grant, award, or other acquisition	-	12,523 Added 9.27%	122,508 Common Stock
Aug 17 2022	BUY Grant, award, or other acquisition	-	21,059 Added 16.07%	109,985 Common Stock
Jan 10 2022	BUY Grant, award, or other acquisition	-	21,726 Added 19.63%	88,926 Common Stock
Aug 20 2021	BUY Open market or private purchase	$53,550 $7.65 p/Share	7,000 Added 9.43%	67,200 Common Stock
Mar 19 2021	BUY Grant, award, or other acquisition	-	15,500 Added 20.48%	60,200 Common Stock

Also insider at

RGNX

REGENXBIO Inc. Healthcare

GVM